Condition: Exudative Macular Degeneration · Sponsor: Medical University of Vienna
The purpose of this study is to implement quantitative assessment tools for the treatment of active neovascular AMD patients in a real-world setting in order to provide advantages for both patients (treatment burden) and healthcare system (scheduling visits/treatments).
This description comes directly from the study's public registry record.
Stefan Sacu, MD · +43 1 40400 · stefan.sacu@meduniwien.ac.at
Ursula Schmidt-Erfurth, MD · +43 1 40400 · ursula.schmidt-erfurth@meduniwien.ac.at
Always discuss trial participation with your own doctor first.
| Department of Ophthalmology, Medical University of Vienna, Austria | Vienna, State of Vienna, Austria | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05093374